These final results, together with a previous report demonstrating that a small-molecule ACKR3 agonist CCX771 reveals anxiolytic-like behavior in mice,2 support the strategy of focusing on ACKR3 as a novel approach to modulate the opioid technique, which could open new therapeutic avenues for opioid-linked Issues. The nutritional supplement is https://leonardoh499vsc7.wikipowell.com/user